endoscopic outcome (recurrence defined as Rutgeerts >i2) and surgical outcome (re-resection).
Background: There is a growing need for non-invasive biomarkers which serve to evaluate inflammatory bowel disease (IBD) activity and response to therapy. Infra-red thermography (IRT) could serve as such biomarker that could complement other non-invasive tests. The aim of our study is to present diagnostic potential of IRT in surveillance of ulcerative colitis (UC) patients. Methods: We included 30 patients with active extensive UC during a follow-up period of 6 months. Patients were diagnosed and treated in concordance to ECCO guidelines on the management of active extensive UC. We also included 30 volunteers in whom UC was excluded by history and physical examination and using noninvasive tests (fecal calprotectin, abdominal US, and CRP). IRT was performed on all patients at enrolment (T1) and at the end of followup (T2) and only at enrolment (T1) for healthy controls. IRT was performed in the same room with stable air temperature and humidity. All measurements were performed by the same experienced operator with an expertise in electroengineering. ThermoMED proprietary software developed at the Ruder Boskovic Institute (Zagreb, Croatia) was used. Subjects were upright 1m from the camera lens which was focused on the subject's abdominal surface. After cooling the abdomen with alcohol, IRT was performed during subsequent 5 min. We obtained maximal, minimal and average temperatures in two predefined contralateral abdominal areas on all subjects. Results: During follow-up 20 patients achieved remission and 10 had persistent active disease. We found significant difference in all measured temperatures between patients and healthy controls, with patients consistently having higher temperatures. Patients not achieving remission had significantly higher T2 temperatures than patients achieving remission (p < 0.05 for all comparisons). Patients achieving remission experienced significant fall in all temperatures (p < 0.001 for all comparisons) at T2. Calprotectin showed significant correlation with all measured temperatures at T2. A cut-off value for T1 average (left contralateral abdominal area) was set at >31.3°C and was able to discriminate active disease from healthy subjects with 86.21% sensitivity and 82.76% specificity; AUC 0.876; p < 0.001. Conclusions: IRT can differentiate between UC patients with active disease, UC patients in remission and healthy controls. Abdominal IRT has the potential of a physical biomarker complementing other standardised biomarkers in diagnosis and surveillance of patients with UC. There is a need for improvement in standardisation of the method and bioinformatics tool, as well as in education of professionals.
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